NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-052-2017-4-SG-48 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection SG DIV 10202003467R Abandoned
NIAID E-131-2020-1-US-01 Anti-Coronavirus Antibodies And Methods Of Use US 63/010,999 Abandoned
NHLBI E-112-2019-0-US-02 A Principal Component Analysis Based Multi-baseline Phase Correction Method For PRF Thermometry US ORD 16/849,313 11301997 Issued PDF
NCI E-008-2018-0-US-07 OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY US National Stage 16/756,420 10876955 Issued PDF
NCI E-097-2017-0-US-05 Macromolecular Platform For Targeting Scavenger Receptor A1 US National Stage 16/756,259 Pending
NIAID E-116-2020-0-US-01 SARS-COV ANTIBODIES AND THEIR USE US 63/010,646 Abandoned
NCI E-014-2018-0-JP-05 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development JP National Stage 2020-521362 Issued
NIAID E-099-2016-1-US-06 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/848,587 Abandoned
NCI E-013-2018-0-AU-04 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19 IMMUNOTHERAPY AU National Stage 2018331517 Pending
NIDA E-077-2019-0-AU-03 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF AU National Stage 2020270992 Issued
NIDA E-077-2019-0-PCT-02 Novel Opotically Active Dopamine D3 Receptor Selective Agonists PCT PCT PCT/US2020/027903 Expired
NIDA E-077-2019-0-EP-05 Novel Opotically Active Dopamine D3 Receptor Selective Agonists EP National Stage 20724970.7 Pending
NIAID E-182-2020-3-US-01 CORONAVIRUS RNA VACCINES US 63/009,005 Abandoned
NCI E-121-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 US 63/008,949 Abandoned
NIDA E-077-2019-0-CA-04 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF CA National Stage 3136151 Pending
NHLBI E-183-2018-0-US-03 3D Bioprinting Of Cardiac Patch With Anisotropic And Perfusable Architecture US National Stage 16/845,329 12029832 Issued PDF
NCI E-065-2019-0-PCT-02 HYBRID NUCLEIC ACID SWITCHES PCT PCT PCT/US2020/027637 Expired
NCI E-213-2014-0-US-07 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors US DIV 16/844,077 10858306 Issued PDF
NCI E-002-2018-0-US-03 METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS US National Stage 16/754,926 Abandoned
NIMH E-174-2006-0-US-15 Intranasal Administration Of Ketamine To Treat Depression US CON 16/844,090 Abandoned
NIAID E-066-2020-0-US-06 Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03) US ORD 16/843,792 11613576 Issued PDF
NIAID E-066-2020-1-PCT-01 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING THE CROSS-OVER-DUAL-VARIABLE DOMAIN (CODV) FORMAT FOR TREATMENT OF HIV INFECTION PCT PCT PCT/US2020/027313 Expired
NIAID E-066-2020-1-CN-12 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION CN National Stage 202080039701.X Pending
NIAID E-066-2020-1-EP-22 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION EP National Stage 20722421.3 Pending
NIAID E-066-2020-1-JP-04 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION JP National Stage 2021-559757 Pending
NIAID E-066-2020-1-CO-16 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION CO National Stage NC2021/0014988 Pending
NIAID E-066-2020-1-CA-11 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION CA National Stage 3136147 Pending
NIAID E-066-2020-1-RU-14 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION RU National Stage 2021132277 Pending
NIAID E-066-2020-1-SG-06 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION SG National Stage 11202111011S Pending
NIAID E-066-2020-1-PH-08 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION PH National Stage 1-2021-500042 Abandoned
NIAID E-066-2020-1-MX-09 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION MX National Stage MX/a/2021/012384 Pending
NIAID E-066-2020-1-ZA-23 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION ZA National Stage 2021/08577 Pending
NIAID E-066-2020-1-IN-19 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING THE CROSS-OVER-DUAL-VARIABLE DOMAIN (CODV) FORMAT FOR TREATMENT OF HIV INFECTION IN National Stage 202117050374 Pending
NIAID E-066-2020-1-HK-01 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION HK EP 62022058135.4 Abandoned
NIAID E-066-2020-1-ID-18 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION ID National Stage P00202109493 Pending
NIAID E-066-2020-1-EG-03 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION EG National Stage PCT 1581/2021 Abandoned
NIAID E-066-2020-1-MY-05 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION MY National Stage PI 2021005603 Abandoned
NIAID E-066-2020-1-TH-20 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION TH National Stage 2101006347 Abandoned
NIAID E-066-2020-1-AU-10 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING THE CROSS-OVER-DUAL-VARIABLE DOMAIN (CODv) FORMAT FOR TREATMENT OF HIV INFECTION AU National Stage 2020273156 Abandoned
NIAID E-066-2020-1-DZ-17 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION DZ National Stage 2063-06-21 Abandoned
NIAID E-066-2020-1-BR-02 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION BR National Stage BR112021020346-0 Pending
NIAID E-066-2020-1-VN-21 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION VN National Stage 1-2021-07042 Pending
NIAID E-066-2020-0-GC-04 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION GC ORD 2020/39509 Abandoned
NCI E-209-2014-0-JP-17 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV 2020-068338 Issued
NIAID E-066-2020-0-AR-03 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION AR ORD 20200100963 Pending
NIAID E-066-2020-0-TW-05 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION TW ORD 109111585 Abandoned
NICHD E-259-2014-1-US-03 MAGNETIC RESONANCE 2D RELAXOMETRY RECONSTRUCTION USING PARTIAL DATA US CON 16/839,931 10802098 Issued PDF
NCI E-181-2017-0-EA-12 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EA National Stage 202090652 Issued
NCI E-181-2017-0-RU-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS RU EA 202090652 Issued
NCI E-175-2016-0-US-15 ANTI-KRAS-G12D T CELL RECEPTORS US DIV 16/838,395 11208456 Issued PDF